Table 2.
Subject | Time point (fever day) | Total number of plasmablast | # paired heavy/light | % recovery | Plasmablast isotype distribution (fully annotated) |
||
---|---|---|---|---|---|---|---|
IgM | IgG | IgA | |||||
Primary #1 | −1 | 38 | 35 | 92.11% | 9 (26.5%) | 4 (11.8%) | 21 (61.8%) |
3 | 79 | 73 | 92.41% | 6 (8.3%) | 22 (30.6%) | 44 (61.1%) | |
Primary #2 | 1 | 236 | 222 | 94.07% | 82 (36.9%) | 55 (24.8%) | 85 (38.3%) |
5 | 40 | 36 | 90.00% | 5 (13.9%) | 24 (66.7%) | 7 (19.4%) | |
Primary #3 | −1 | 26 | 21 | 80.77% | 2 (10.5%) | 4 (21.1%) | 13 (68.4%) |
2 | 154 | 133 | 86.36% | 39 (29.8% | 53 (40.4%) | 39 (29.8%) | |
Secondary #1 | 0 | 435 | 396 | 91.03% | 12 (3%) | 352 (89.1%) | 31 (7.8%) |
1 | 549 | 494 | 89.98% | 10 (2%) | 428 (86.8%) | 55 (11.2%) | |
7 | 9 | 8 | 88.89% | 3 (37.5%) | 5 (62.5%) | 0 (0%) | |
Secondary #2 | −1 | 118 | 104 | 88.14% | 3 (2.9%) | 61 (59.2%) | 39 (37.9%) |
1 | 697 | 642 | 92.11% | 17 (2.7%) | 560 (87.4%) | 64 (10%) | |
5 | 37 | 33 | 89.19% | 6 (18.8%) | 6 (18.8%) | 20 (62.5%) | |
Secondary #3 | 0 | 61 | 54 | 88.52% | 14 (25.9%) | 22 (40.7%) | 18 (33.3%) |
1 | 155 | 141 | 90.97% | 18 (12.8%) | 82 (58.2%) | 41 (29.1%) | |
5 | 83 | 75 | 90.36% | 11 (14.7%) | 40 (53.3%) | 24 (32%) |